Management Report
Management Report

5.2 Asset and Financial Position of Bayer AG

Bayer AG Summary Statements of Financial Position according to the German Commercial Code[Table 3.26]
 Dec. 31, 2009Dec. 31, 2010
 € million€ million
ASSETS  
   
Noncurrent assets  
Intangible assets, property, plant and equipment395347
Financial assets34,59434,267
 34,98934,614
   
Current assets  
Receivables from subsidiaries1,9282,040
Remaining receivables, other assets400464
Cash and cash equivalents, marketable securities1,8622,131
 4,1904,635
   
Total assets39,17939,249
   
EQUITY AND LIABILITIES  
   
Equity14,39114,478
   
Provisions3,2583,328
   
Other liabilities  
Bonds and notes, liabilities to banks7,0295,842
Payables to subsidiaries13,96515,149
Remaining liabilities536452
 21,53021,443
   
Total equity and liabilities39,17939,249
The asset and liability structure of Bayer AG is dominated by its role as a holding company in managing the subsidiaries and financing corporate activities. This is primarily reflected in the high level of investments in affiliated companies and of receivables from, and payables to, Group companies.
Total assets of Bayer AG were at the previous year’s level of €39.2 billion. A €0.4 billion decline in noncurrent assets was offset by an increase of the same amount in current assets.
Property, plant and equipment and intangible assets remained virtually unchanged, while financial assets declined by just €0.3 billion to €34.3 billion. Financial assets included investments in subsidiaries amounting to €33.7 billion (2009: €34.1 billion), or 85.9% (2009: 87.1%) of total assets.
Receivables from subsidiaries amounted to €2.0 billion (2009: €1.9 billion), while payables to subsidiaries totaled €15.1 billion (2009: €14.0 billion). These amounts accounted for 5.2% of total assets and 38.6% of total equity and liabilities, respectively.
Of the unchanged amount of €39.2 billion in total assets, €14.5 billion (2009: €14.4 billion) was equity-financed. The equity ratio rose from 36.7% to 36.9%. Equity was increased by the €1,245 million net income, but diminished by the €1,158 million dividend payment for 2009.
Provisions increased by €0.1 billion compared with the start of the year to €3.3 billion because of higher provisions for taxes.
Other liabilities were almost unchanged at €21.4 billion (net of deductible receivables; 2009: €21.5 billion). However, the financial debt included here declined by €1.3 billion to €23.0 billion. The decrease included a €1.2 billion drop in external financial debt, comprising a €0.9 billion reduction in liabilities to banks and the repayment of a €0.3 billion bond issued in 2007.
Last updated: February 28, 2011

http://www.annualreport2010.bayer.com/en/asset-and-financial-position-of-bayer-ag.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Services

Full Year 2010 Results

Info

Special Interest